The global Drug Eluting Balloon Market Growth Accelerated by Increased Use in Percutaneous Coronary Interventions
Drug eluting balloons are increasingly being used for percutaneous coronary interventions (PCI) as an alternative to bare metal and drug eluting stents. Drug eluting balloons are inflatable angioplasty balloons coated with an antiproliferative drug, which is slowly released at the treatment site during coronary angioplasty to prevent restenosis. They provide advantages such as reduced risk of late stent thrombosis and a lower rate of restenosis. They also avoid overstretching and damage to arterial walls caused by stents. The global Drug Eluting Balloon Market is estimated to be valued at US$ 667.78 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The primary trend fueling the growth of the drug eluting balloon market size is the increasing adoption of drug eluting balloons over drug eluting stents during PCI procedures. Drug eluting balloons are ass...